Search
Returning search results with filters:
Remove filter for
Issue: Health products
Remove filter for
Last updated: 2019
Remove filter for
Type: Alert
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
- (-) 2019
- December 20198 results available
- November 20193 results available
- October 20197 results available
- September 20196 results available
- August 20191 results available
- July 20199 results available
- June 20197 results available
- May 20199 results available
- April 20198 results available
- March 20195 results available
- February 20193 results available
- January 20193 results available
Displaying 46 - 60 of 69 items.
Unauthorized products may pose serious health risks (May 17, 2019 - Part 1)
AlertPublic advisory | 2019-05-17
Health Canada is advising Canadians about the potential health risks associated with unauthorized cell therapy treatments such as stem cell therapy
AlertInformation update | 2019-05-15
Foreign product alert (FPA)
AlertForeign product alert | 2019-05-10
Health Canada seizes a new type of “popper” containing ethyl chloride in Scarborough, ON
AlertPublic advisory | 2019-05-09
Testing finds pharmaceutical ingredients in unauthorized health products seized from Sunrise Lee Chinese Herbs Centre in Calgary, Alberta
AlertInformation update | 2019-05-08
Undeclared drug ingredients may pose serious health risks
AlertForeign product alert | 2019-04-30
Multiple unauthorized prescription drugs seized from Vanier store in Ottawa, Ontario, may pose serious health risks
AlertPublic advisory | 2019-04-25
Unauthorized products may pose serious health risks (December 10, 2018 to April 17, 2019)
AlertPublic advisory | 2019-04-17
Intragastric Balloons and Potential Risk of Gastric and Esophageal Perforation, Pancreatitis, and Overinflation
AlertHealth professional risk communication | 2019-04-17
Multiple unauthorized eye solutions and an acne gel sold at two stores in the Lower Mainland of BC may pose serious health risks
AlertPublic advisory | 2019-04-15
Health Canada testing identifies additional health risks involving unauthorized products sold by A1 Herbal Ayurvedic Clinic Ltd.
AlertInformation update | 2019-04-12
PrBENLYSTA (belimumab) - Increased Risk of Serious Depression, Suicidal Ideation or Behaviour, or Self-Injury
AlertHealth professional risk communication | 2019-04-04
Health Canada advises Allergan of its intent to suspend its licences for Biocell breast implants as a precautionary measure
AlertInformation update | 2019-04-04
DARZALEX (daratumumab) and Hepatitis B Virus Reactivation
AlertHealth professional risk communication | 2019-03-25